Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Hemangioma, Capillary 7 Hemangioma 5 Vascular Malformations 1 Sturge-Weber Syndrome 1 Premature Birth 1 Melanoma 1 Hemangioma, Cavernous 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Sirolimus 2 mirdametinib 1 Vincristine 1 Timolol 1 Tablets 1 Sildenafil Citrate 1 Ointments 1 Mupirocin 1 Lasers, Dye 1 Everolimus 1 Blood Specimen Collection 1 Bioseal 1 Alpelisib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Vascular Malformations × Timolol × Clear all

NCT01408056 2014-01-17

TOUCH

Children's Hospital of Philadelphia

Phase 2 Withdrawn

Hemangioma, Hemangioma, Capillary, Vascular Malformations

Data powered by HemOnc (CC BY 4.0) Colophon ⚡